Jump to:
Mallory Ursul practices in the intellectual property transactions group and advises public and private companies, investors, entrepreneurs, and other clients on a wide range of strategic transactions, including license agreements, complex collaborations, mergers and acquisitions, supply and distribution agreements, and other commercial transactions where intellectual property is a key consideration. Mallory has represented clients in a variety of industries including life sciences, technology, software, and consumer products.
Experience
- Advised Sverica Capital Management in its strategic investment in Electronic Source Company, an electronic manufacturing services company serving the Aerospace & Defense and Space markets with high-reliability circuit card assemblies.
- Advised Novo Nordisk in a multi-year partnership with NanoVation Therapeutics to develop genetic medicines for rare and cardiometabolic diseases.
- Advised Lifespan, a leading academic healthcare system based in Providence, Rhode Island, in its acquisition of Saint Anne’s Hospital in Fall River and Morton Hospital in Taunton, Massachusetts, as part of the Steward Health Care System bankruptcy.
- Advised Gilgamesh Pharmaceuticals in a collaboration and option-to-license agreement with AbbVie to develop next-generation therapies for psychiatric disorders.
- Advised a major biotechnology company in a license and option agreement with a clinical-stage immunobiology company.
- Advised Verastem Oncology in a discovery and development collaboration with GenFleet Therapeutics to advance three oncology discovery programs targeting RAS pathway-driven cancers.
- Advised HotSpot Therapeutics in an exclusive, worldwide collaboration and option to license agreement with AbbVie for HotSpot's new class of small molecule IRF5 modulators for the treatment of severe autoimmune diseases.
- Advised a medical equipment manufacturer in completing the acquisition of a company that designs and manufacturers cardiac mapping and navigation systems.
- Advised clinical stage precision cancer biopharmaceutical company IDRx in licensing transactions with Germany-based Merck KGaA and Blueprint Medicines to secure rights to IDRX-42 and IDRX-73- two small molecule tyrosine kinase inhibitors.
- Advised Ginkgo Bioworks, a horizontal platform for cell programming, in an agreement with Bayer to expand Ginkgo’s platform capabilities in agricultural biologicals.
- Advised Ginkgo Bioworks, a horizontal platform for cell programming, in an agreement to acquire biotechnology company Zymergen in an all-stock transaction that values Zymergen at approximately $300 million.
- Advised Sezzle Inc. in its definitive agreement to be acquired by Zip Co. Limited.
- Advised TPG Capital and its portfolio company Nintex, a workflow automation company, in the acquisition of Kryon, a provider of robotic process automation (RPA).
- Advised Baring Private Equity Asia in the acquisition of the Healthcare Services business of Hinduja Global Solutions Limited.
- Advised a medical device company in the acquisition of a provider of an innovative Radio Frequency ablation technology treatment.
- Advised Audax Private Equity in its acquisition of a majority stake in Flashpoint, a global leader in actionable threat intelligence.
- Advised ServiceMax Inc., the leader in asset-centric field service management, in a business combination agreement with Pathfinder Acquisition Corporation, a publicly traded special purpose acquisition company to become a publicly traded company.
- Advised Cove Hill Partners in the acquisitions of Ungerboeck Systems International and EventBooking.com, two leading software providers of event and venue management tools.
- Advised GHO Capital LLP in its acquisition of Velocity Clinical Research, an integrated site organization for clinical trials, offering dedicated site capabilities to help biopharmaceutical and contract research organization customers find the right patients for their studies.
- Advised H.I.G. Capital in its potential $225 million investment in eHealth Inc., a leading health insurance marketplace.